Immunosuppressive chemotherapy and malignancy.
D000361:Agammaglobulinemia / Q000150:complications; D000818:Animals; D000831:Animals, Newborn; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001424:Bacterial Infections / Q000209:etiology; D002273:Carcinogens; D005246:Feedback; D006801:Humans; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes / Q000150:complications; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation; D008223:Lymphoma / Q000209:etiology; D051379:Mice; D009181:Mycoses / Q000209:etiology; D009369:Neoplasms / Q000188:drug therapy*; D011830:Radiation Effects; D013601:T-Lymphocytes / Q000276:immunology; D013934:Thymectomy; D013950:Thymus Gland / Q000002:abnormalities / Q000276:immunology; D014181:Transplantation Immunology / Q000528:radiation effects; D014777:Virus Diseases / Q000209:etiology
D000961:Antilymphocyte Serum; D002273:Carcinogens; D007166:Immunosuppressive Agents